Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?

por Jehle, Alexander B, Xu, Yaqin, DiMaria, Joseph D, Epstein, Frederick H, French, Brent A, Roy, R Jack, Carey, Robert M, Kramer, Christopher M
Publicado 2009